Details for 2019202083
Up to date per 02.04.2026
Actions
Details for 2019202083
Granted/Registered
European Patent
15.07.2020 A
10.08.2022 B1
18.06.2009
US
26895409 P
A61K 38/095 20190101AFI20210504BHEP
Owner
Serenity Pharmaceuticals LLC7025 Langer Drive, Suite 205 Mississauga, ON L5N 0E8CA
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
FEIN, Seymour476 Canoe Hill Road New Canaan, CT Connecticut CT 06840US
Information about Fees